Relmada Therapeutics Inc (RLMD) — Long-term Investment Intensity

Latest as of March 2018: 6.0%

Relmada Therapeutics Inc (RLMD) has a Long-term Investment Intensity of 6.0% as of March 2018. Long-term investments of $289.87K represent 6.0% of total assets of $4.80 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Relmada Therapeutics Inc net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

6.0%
LT Investments / Total Assets

Long-term Investments

$289.87K
USD

Total Assets

$4.80 Million
USD

Country

USA
NASDAQ

Relmada Therapeutics Inc Long-term Investment Intensity (2016–2016)

This chart shows how Relmada Therapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2016 to 2016. As of March 2018, the intensity stands at 6.0%, reflecting long-term investments of $289.87K against total assets of $4.80 Million USD. Also explore RLMD total asset value for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Relmada Therapeutics Inc (2016–2016)

The table below presents the year-by-year Long-term Investment Intensity for Relmada Therapeutics Inc from 2016 to 2016, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see RLMD stock market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2016 3.3% $337.73K $10.24 Million
pp = percentage points